Preview Mode Links will not work in preview mode

Jun 7, 2024

Featuring perspectives from Dr Matthew D Galsky and Dr Ashish M Kamat, including the following topics:

  • Introduction: Urologist for Life (0:00)
  • Non-Muscle-Invasive Urothelial Bladder Cancer (UBC) Update (9:54)
  • Enfortumab Vedotin/Pembrolizumab Now and in the Future (30:21)
  • HER2-Positive UBC (37:33)
  • Future Directions —...


May 7, 2024

Featuring perspectives from Dr Matthew D Galsky, including the following topics:

  • HER2 alterations in urothelial cancer and current targeting approaches (0:00)
  • Key findings supporting the use of trastuzumab deruxtecan for patients with HER2-overexpressing cancers as part of the Phase II DESTINY-PanTumor02 study (9:39)


Apr 25, 2024

Featuring an interview with Dr Emmanuel S Antonarakis, including the following topics:

  • Perspectives on advances in the management of prostate cancer over the last decade (0:00)
  • Nonmetastatic high-risk prostate cancer and androgen deprivation therapy (ADT) intensification with abiraterone: Insights from the STAMPEDE...


Apr 19, 2024

Featuring perspectives from Dr Matthew D Galsky and Dr Jonathan E Rosenberg, including the following topics.

  • Introduction (0:00)
  • Nonmetastatic Urothelial Bladder Cancer (UBC) — Dr Galsky (5:45)
  • Metastatic UBC — Dr Rosenberg (31:51)

CME information and select...


Apr 19, 2024

Featuring perspectives from Dr Eric Jonasch and DR Brian Rini, including the following topics.

  • Introduction (0:00)
  • Current Management of Metastatic Clear Cell Renal Cell Carcinoma (RCC) — Dr Rini (5:11)
  • Treatment Approaches for Nonmetastatic RCC; Optimal Care of Patients with Non-Clear Cell RCC — Dr...